Key Features to Consider in the Best Nebulizer Machine in India - Have you ever bought a health device that ended up ...
The United States nebulizer market is set to grow from US$ 466.55 million in 2024 to US$ 730.62 million by 2033, with a CAGR of 5.11%. This growth is driven by the rising prevalence of respiratory ...
TipRanks on MSN
Liquidia Technologies Secures Licensing Deal with Vectura
An announcement from Liquidia Technologies ( ($LQDA) ) is now available. On October 27, 2025, Liquidia Technologies entered into an exclusive ...
Generic Tobramycin Inhalation Solution marks the first cystic fibrosis (CF) product in the Company’s portfolio-Antibiotic is primarily used for ...
Detailed price information for United Therapeutic (UTHR-Q) from The Globe and Mail including charting and trades.
Discusses Innovations in Inhaled Treprostinil Therapies and Updates on Drug Delivery Technologies October 28, 2025 2:00 ...
An updated guide to timing, parts, costs and coordination so you don’t get stuck with penalties or surprises at 65.
Texas officials promised to help Rochelle care for her grandkids after taking them from their parents. But the help she needed never arrived.
News-Medical.Net on MSN
Study sheds light on the practice patterns of aerosol drug therapy in patients with ARDS
A new review led by Associate Professor Sanjay Singhal from Dr. Ram Manohar Lohia Institute of Medical Sciences sheds light ...
A new review led by Associate Professor Sanjay Singhal from Dr. Ram Manohar Lohia Institute of Medical Sciences sheds light on the prevalence and ...
On the surface, a Medicare Advantage plan that charges no monthly premium seems like a better deal than original Medicare with a Medigap and Part D drug plan, which have monthly premiums but typically ...
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that it has commenced an underwritten public offering of shares of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results